MS in Medical Cannabis Science & Business
- Program Director
- Associate Professor
Fully online program designed to provide students with the knowledge in cannabis medicine, science, business, and policies, required to enter the cannabis industry, support patients, add to existing research and develop innovative cannabis business models.
Application Process & Deadlines
Applications for the Master program are considered on a rolling-admissions basis throughout the year, and newly matriculated students may begin coursework in any academic term.
AUGUST 1 - Fall
DECEMBER 1 - Spring
APRIL 1 - Summer
Across the globe, cannabis medicalization and legalization are having a profound effect on the world. Over half of the United States have already legalized cannabis in some form and the legal cannabis industry has been growing at a rate faster than any other industry over the past four years, becoming the single greatest job creation engine in America.
The potential for new pharmacotherapies working through unique mechanisms of action offer hope for many unmet clinical needs. The increasing demand for medical cannabis has created a noticeable need for cannabis education for healthcare professionals and, more in general, the need for an educated workforce with expertise in the therapeutic effects, science and business of cannabis.
The Master of Science (MS) in Medical Cannabis Science and Business program is designed to prepare students to enter the cannabis field as researchers, scientists, entrepreneurs, or healthcare providers that can better support patients in need of alternative treatment options. The MS degree program encompasses three stackable graduate certificates in the following areas:
Students in the Masters of Science program will have the flexibility to choose which course to take each semester, in what order to take them, and which certificate to pursue first. Students may enroll into the program in Fall, Spring or Summer and can decide between full-time and part-time options to complete the required 33 credits. All cannabis courses are online and mostly asynchronous.
The following represents the course offerings by semester:
|CMD 503 Pathology Potentially Responsive to Cannabis|
|CSC 511 Botany and Chemistry of Cannabis|
|CBU 501 Emerging Issues in the Cannabis Industry|
|CMD 504 Conventional & Cannabinoid Therapy of Disease|
|CSC 512 Forensic Analysis of Cannabis and Cannabis-Derived Products|
|CBU 506 Essentials of Cannabis Financial and Operations Analysis|
|CMD 505 Health Implications of Medicinal Cannabis|
|CSC 513 Cannabinoid Pharmacology|
|FALL, SPRING, SUMMER COURSES|
|iMBA 604 Business Model Innovation|
|CRS 600 Applied Research Design & Methods|
|CRS 610 Cannabis Capstone Project|
As you complete the courses toward the M.S. degree you will also earn cannabis certificates in:
- Cannabis Medicine (CMD 503, CMD 504, CMD 505)
- Cannabis Science (CSC 511, CSC 512, CSC 513)
- Cannabis Business (CBU 501, CBU 506, iMBA 604)
If you are not ready to commit to a M.S. degree or a full certificate, take a course or two as a non-degree student (non-matriculated option) - see information
Brooke Worster, MD
Dr. Brooke Worster completed her internal medicine and chief residency at Temple University and her pain and palliative care fellowships at Massachusetts General Hospital and Dana Farber Cancer center.
Jack Henion, PhD
Professor Jack Henion is Emeritus Professor of Toxicology at Cornell University where he was a member of the College of Veterinary Medicine commencing in 1976.
Marilyn Huestis, PhD
Dr. Marilyn Huestis was the former Chief of Chemistry and Drug Metabolism at NIDA’s Intramural Research Program (IRP) where she conducted controlled drug administration studies.
Mahmoud ElSohly, PhD, BCFE, BCFM
Mahmoud A. ElSohly is a Research Professor at The National Center for Natural Products Research, and Professor of Pharmaceutics and Drug Delivery, School of Pharmacy, University of Mississippi (UM).
Sara Jane Ward, PhD
Dr. Sara Jane Ward is an Assistant Professor in the Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University.
Thomas Jefferson University recognizes the term “cannabis” encompasses a wide range of products that are both inclusive and exclusive of tetrahydrocannabinol compounds. Hemp and other products void of any psychoactive elements are legal in a number of jurisdictions. While products containing psychoactive compounds have been legalized in some states and local jurisdictions, such remains illegal at the federal level. Thomas Jefferson University supports and adheres to the requirements of the Drug-Free Schools and Communities Act of 1989 (DFSCA), and does not allow, promote, endorse or condone illegal use, possession or distribution of illegal substances. Thomas Jefferson University’s program teaches theories and principles of business related to the industry along with a responsible perspective related to legal, medical and other considerations. Upon completion of the program, the Career Services department will be able to assist the graduate with traditional career search preparation activities and employment opportunities that are deemed legal according to federal guidelines; however, the department will be unable to assist with direct employment assistance in areas working with products or supply chain entities that do not meet federal regulations and approvals.